Links & Networks

IC2PerMed “twin sister” project, Sino-EU PerMed project started in January 2020. The project received a two million euros grant from the European Framework Programme Horizon 2020. It aims to foster the cooperation between Europe and China in Personalised Medicine in the next four years.

ERA PerMed (2017-2022) is a ERA-Net Cofund Action on personalised medicine, supported by 32 partners from 23 countries and cofunded by the European Commission. It aims to align national and regional research strategies and funding activities, promoting excellence, reinforcing the competitiveness of European players in personalised medicine, and enhancing the collaboration with non-EU countries.

HEcoPerMed aims to identify the best health economic modelling and payment strategies for personalised medicine to differentiate between the promises of personalised medicine and reality, and to stimulate the adoption of promising personalised medicine approaches across the EU.

PERMIT will be based on a series of workshops where the project participants and partners invite selected experts to address the various aspects of methodology, design, data management, analysis and interpretation in personalised medicine research programmes. The objective is to reach consensus and publish recommendations on methodological standards to ensure the scientific excellence, validity, robustness and reproducibility of results, and the acceptability of the results generated by personalised medicine programmes.

SAPHIRe will actively engage with European regions, including sparsely populated and remote regions and regions with different innovation levels. SAPHIRe will host a series of interactive events to understand the barriers and obstacles that exist around the implementation of personalised medicine. SAPHIRe will engage with regional stakeholders (including policy makers, industrial, healthcare and academic sectors) in a two-way discussion, with a view to supporting collaborative efforts and networking activities between regions in the area of personalised medicine.

The project Regions4PerMed contributes to the achievement of the objectives of the European strategy launched in 2011 with the European Council Conclusion: Towards modern, responsive and sustainable health systems (2011/C 202/04) on and modernisation of the European Healthcare system. In the 2011/C 202/04, particular stress is put on the role of strategic investments in healthcare and the importance of an integrated and interoperable health data sharing system.

In order to strengthen the global efforts on Personalized Medicine and the cooperation of Europe (EU) with Latin American and Caribbean (LAC)  countries , the EULAC PerMed project, funded by the Horizon 2020 Programme of the European Commission, has been launched in January 2019. A unique bi-regional consortium of governmental and funding organisations, with the support of leading stakeholders as associated partners, will be in charge of developing the project until December 2021.
EULAC PerMed has the ambition to engage LAC countries in the International Consortium on Personalized Medicine (ICPerMed) and in the ERANet ERAPerMed with the aim at advancing in the implementation of the Action Plan of ICPerMed. EULAC PerMed will be the vehicle for: